We conducted 25 research studies in 10 countries in Africa and Asia to answer key questions on optimizing the delivery of artemisinin-based combination therapy (ACT) - the first-line treatment recommended by the WHO for malaria.
Each of our studies addressed one or more of our research themes: access, targeting, safety and quality.
We took a multi-disciplinary approach to our work, looking at the effectiveness of ACTs over time, cost-effectiveness of delivery strategies, acceptability, safety, and how to improve ACT use by prescribers and patients. We tested a range of strategies based on Rapid Diagnostic Tests and targeted behaviour change communication methods.
You can download a booklet that summarises our findings. The Project Profiles give you more detailed information about each study, and our Publications section provides you with a list of all peer-reviewed journal articles published by the ACT Consortium.
We also produced useful resources to improve the quality of research being done in the field. These guidelines were created to benefit our consortium members as well as other colleagues from around the world involved in researching ACTs and their use in malaria endemic countries. Many of these resources have been compiled into a Starter Kit that you can adapt to your own work.
ACT Consortium 2007-2015: Leaving a legacy for malaria policy from ACT Consortium on Vimeo.
Check out the videorn